Research reading room
Hepatocellular Carcinoma (CLCA, Nature 2024)
Summary
Hepatocellular Carcinoma (CLCA, Nature 2024) is a study catalogued by cBioPortal DataHub under the cancer-type code hcc. EvidenceHelix groups it with liver, bile duct and gallbladder studies.
Study description
The Chinese Liver Cancer Atlas (CLCA) project. Deep whole-genome sequencing of 494 hepatocellular carcinomas and their matched normals. Data from CLC Atlas (http://lifeome.net:8080/clca/#/).
Text as published in the source's study metadata.
Citation & PubMed
Chen L et al. Nature 2024
Linked PubMed records: PMID 38355797
Source & licence
Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.
Source metadata
- Study identifier
- hcc_clca_2024
- Short name
- HCC (CLCA 2014)
- Source cancer-type code
- hcc
- Reference genome
- not given
- Source access groups
- PUBLIC
- Original study
- View on cBioPortal
- Metadata file
- meta_study.txt at e1b75cd25b
- Database licence
- ODC Open Database License (ODbL) 1.0
Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.
Citations
Chen L et al. Nature 2024
Citation counts are not part of the source metadata and are not shown.
Related studies
-
Hepatocellular Carcinoma (MERiC/Basel, Nat Commun. 2022)
Whole-exome sequencing of 122 Hepatocellular carcinomas and their matched normals. Dataset was generated in 2021 by MERiC and Charlotte Ng (hg19 original; Basel/Bern research pipeline).
Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1 -
Hepatocellular Carcinomas (INSERM, Nat Genet 2015)
Whole-exome sequencing of 243 liver tumors and matched normals.
Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1 -
Liver Hepatocellular Carcinoma (AMC, Hepatology 2014)
Whole exome sequencing of 231 hepatocellular carcinomas and matched normal tissue pairs.
Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1 -
Liver Hepatocellular Carcinoma (RIKEN, Nat Genet 2012)
Whole-genome sequencing of 27 hepatocellular carcinoma tumor/norma pairs from RIKEN.
Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1 -
Hepatocellular Carcinoma (MSK, Clin Cancer Res 2018)
MSK-IMPACT sequencing of 127 Hepatocellular Carcinoma tumor samples with matched normals.
Liver, bile duct and gallbladderMSK studiesSource code hccPubMed 1 -
Hepatocellular Carcinoma (MSK, Clin Cancer Res 2024)
Targeted sequencing of 1,370 hepatobiliary cancer samples (with 1366 matched normals) via MSK-IMPACT. This data is available under the Creative Commons BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-…
Liver, bile duct and gallbladderMSK studiesSource code hccPubMed 1 -
Hepatocellular Carcinoma (MSK, JCO Precis Oncol 2023)
Targeted sequencing of 51 hepatocellular carcinoma patients and their matched normal samples via MSK-IMPACT.
Liver, bile duct and gallbladderMSK studiesSource code hccPubMed 1 -
Liver Hepatocellular Adenoma and Carcinomas (MSK, PLOS One 2018)
Targeted sequencing of tumor/normal pairs of 9 LIAD and 10 HCC patients via MSK-IMPACT platform.
Liver, bile duct and gallbladderMSK studiesSource code hccPubMed 1